However, it is not known why and how the presence of RA leads to these outcomes in the child. Additionally, it is unclear
whether these adverse birth outcomes are the result of exposure of the fetus to a “disease (RA) environment” or to RA
medications taken by the mother before and/or during pregnancy.
Our research will provide novel insight into whether the expression levels of different genes in the mother during pregnancy - in response to RA
and/or to RA medications - influence the health of the children born from those pregnancies.